The Biedermann Medtech Group, provider of next-generation spinal and extremity implant systems and procedural solutions, commenced a strategic transformation of its U.S. operations. Biedermann will expand its focus beyond product distribution to a broader platform of integrated services and solutions designed to reshape its U.S. business model.
As part of this transition, Biedermann Motech will discontinue direct distribution of its product lines for spinal and extremity surgery in the U.S. market in the near future.
In the next phase of this transformation, Biedermann Motech will leverage its strategic partnership with Biedermann Technologies to commercialize its substantial U.S. patent and technology portfolio with a next-generation business model. This model will include licensing opportunities for its U.S. spine and extremity product portfolio, patents, and technologies, complemented by a suite of value-added services.
Substantial challenges presented by the European Union’s Medical Device Regulation have led to increased interest in the CE-marked Biedermann spine product portfolio. Consequently, Biedermann Motech will continue to pursue and expand its direct business opportunities outside of the U.S.
The Biedermann Medtech Group, provider of next-generation spinal and extremity implant systems and procedural solutions, commenced a strategic transformation of its U.S. operations. Biedermann will expand its focus beyond product distribution to a broader platform of integrated services and solutions designed to reshape its U.S. business...
The Biedermann Medtech Group, provider of next-generation spinal and extremity implant systems and procedural solutions, commenced a strategic transformation of its U.S. operations. Biedermann will expand its focus beyond product distribution to a broader platform of integrated services and solutions designed to reshape its U.S. business model.
As part of this transition, Biedermann Motech will discontinue direct distribution of its product lines for spinal and extremity surgery in the U.S. market in the near future.
In the next phase of this transformation, Biedermann Motech will leverage its strategic partnership with Biedermann Technologies to commercialize its substantial U.S. patent and technology portfolio with a next-generation business model. This model will include licensing opportunities for its U.S. spine and extremity product portfolio, patents, and technologies, complemented by a suite of value-added services.
Substantial challenges presented by the European Union’s Medical Device Regulation have led to increased interest in the CE-marked Biedermann spine product portfolio. Consequently, Biedermann Motech will continue to pursue and expand its direct business opportunities outside of the U.S.
Copy to clipboard 
